Patents by Inventor Chie KAWAGUCHI

Chie KAWAGUCHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-lipoarabinomannan antibody and immunoassay for acid-fast bacillary infection using the antibody
    Patent number: 9512206
    Abstract: The present invention provides a monoclonal antibody that specifically binds to acid-fast bacillary lipoarabinomannan, particularly tubercle bacillary lipoarabinomannan, the antibody being set forth below: (A) a monoclonal antibody comprising a heavy chain variable region and a light chain variable region joined via a linker, the heavy chain variable region comprising heavy chains CDR1 to CDR3 shown in (a) to (c) below, and the light chain variable region comprising light chains CDR1 to CDR3 shown in (d) to (f) below: (a) heavy chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 1, (b) heavy chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 2, (c) heavy chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 3, (d) light chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 4, (e) light chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 5, and (f) light chain CDR1 consisting of the amino acid sequence set fo
    Type: Grant
    Filed: February 28, 2013
    Date of Patent: December 6, 2016
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Kiyonori Katsuragi, Masataka Togashi, Tetsuya Oda, Ryuta Ito, Chie Kawaguchi, Yoko Saijo, Daisuke Koga, Makoto Matsumoto, Mamoru Fujiwara, Kenji Ono
  • ANTI-LIPOARABINOMANNAN ANTIBODY AND IMMUNOASSAY FOR ACID-FAST BACILLARY INFECTION USING THE ANTIBODY
    Publication number: 20160083458
    Abstract: The present invention provides a monoclonal antibody that specifically binds to acid-fast bacillary lipoarabinomannan, particularly tubercle bacillary lipoarabinomannan, the antibody being set forth below: (A) a monoclonal antibody comprising a heavy chain variable region and a light chain variable region joined via a linker, the heavy chain variable region comprising heavy chains CDR1 to CDR3 shown in (a) to (c) below, and the light chain variable region comprising light chains CDR1 to CDR3 shown in (d) to (f) below: (a) heavy chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 1, (b) heavy chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 2, (c) heavy chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 3, (d) light chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 4, (e) light chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 5, and (f) light chain CDR1 consisting of the amino acid sequence set
    Type: Application
    Filed: February 28, 2013
    Publication date: March 24, 2016
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Kiyonori KATSURAGI, Masataka TOGASHI, Tetsuya ODA, Ryuta ITO, Chie KAWAGUCHI, Yoko SAIJO, Daisuke KOGA, Makoto MATSUMOTO, Mamoru FUJIWARA, Kenji ONO